Galit Alter

发表

Exploiting glycan topography for computational design of Env glycoprotein antigenicity

Douglas A. Lauffenburger, Michael Tiemeyer, Wen-Han Yu, 2018, PLoS Comput. Biol..

Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence features

Marco Carone, Noah Simon, Craig A Magaret, 2019, PLoS Comput. Biol..

Machine Learning Methods Enable Predictive Modeling of Antibody Feature:Function Relationships in RV144 Vaccinees

Chris Bailey-Kellogg, Jaranit Kaewkungwal, Todd J. Suscovich, 2015, PLoS Comput. Biol..

The HIV-1 Glycan Shield: Strategically Placed Kinks in the Armor Improve Antigen Design.

Galit Alter, Christina Beatrice Karsten, G. Alter, 2017, Cell reports.

Comprehensive Data Integration Approach to Assess Immune Responses and Correlates of RTS,S/AS01-Mediated Protection From Malaria Infection in Controlled Human Malaria Infection Trials

Raphael Gottardo, Savita Pahwa, William Chad Young, 2021, Frontiers in Big Data.

Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses

Jonathan R. Lai, Galit Alter, Marnie L. Fusco, 2015, Journal of Virology.

De Novo Generation of Escape Variant-Specific CD8+ T-Cell Responses following Cytotoxic T-Lymphocyte Escape in Chronic Human Immunodeficiency Virus Type 1 Infection

Galit Alter, Christian Brander, Eric S. Rosenberg, 2005, Journal of Virology.

Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap

James E Crowe, Galit Alter, J. Crowe, 2018, PLoS pathogens.

HLA Class I Subtype-Dependent Expansion of KIR3DS1+ and KIR3DL1+ NK Cells during Acute Human Immunodeficiency Virus Type 1 Infection

Galit Alter, Eric S. Rosenberg, Mary Carrington, 2009, Journal of Virology.

Differential natural killer cell–mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes

William H. Carr, Todd J. Suscovich, Hendrik Streeck, 2007, The Journal of experimental medicine.

High degree of inter-clade cross-reactivity of HIV-1-specific T cell responses at the single peptide level

Galit Alter, Christian Brander, M. Altfeld, 2005, AIDS.

International AIDS Society global scientific strategy: towards an HIV cure 2016

Richard Jefferys, David Margolis, Jintanat Ananworanich, 2016, Nature Medicine.

Single-cell analysis of the dynamics and functional outcomes of interactions between human natural killer cells and target cells.

J Christopher Love, Galit Alter, Yvonne J Yamanaka, 2012, Integrative biology : quantitative biosciences from nano to macro.

Loss of HIV-1–specific CD8+ T Cell Proliferation after Acute HIV-1 Infection and Restoration by Vaccine-induced HIV-1–specific CD4+ T Cells

Galit Alter, Eric S. Rosenberg, Daniel E. Kaufmann, 2004, The Journal of experimental medicine.

Multiplexed Affinity-Based Separation of Proteins and Cells Using Inertial Microfluidics

Han Wei Hou, Jongyoon Han, Aniruddh Sarkar, 2016, Scientific reports.

Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys

Jessica Jimenez, Galit Alter, Kayvon Modjarrad, 2016, Science.

Ultra-Sensitive High-Resolution Profiling of Anti-SARS-CoV-2 Antibodies for Detecting Early Seroconversion in COVID-19 Patients

David R. Walt, Tal Gilboa, Galit Alter, 2020 .

Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection.

Hendrik Streeck, Galit Alter, Nesli Basgoz, 2005, Blood.

The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies

Daphne Koller, George M. Church, Jonathan Laserson, 2013, PLoS pathogens.

Dynamics and significance of the antibody response to SARS-CoV-2 infection

Galit Alter, Jared Feldman, Stephen A. Lauer, 2020, medRxiv.

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

Galit Alter, David C Montefiori, Nigel Garrett, 2018, The Lancet.